drugset / Trial / NCT05795816
Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Testofen (a specialised extract of Trigonella foenum-graecum (Fenugreek) seed) compared to placebo on post COVID-19 symptoms in otherwise healthy participants 18 years and over.
Timeline
- Start
- 2023-10-25
- Primary completion
- 2025-01-30
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Testofen | Unknown | 300 mg | Oral |